how to cite this article: salehpour sh. clinical manifestations of type 1 gaucher disease. iran j child neurol autumn 2012; 6:4 (suppl. 1):13-14. pls see pdf. refe r ences 1. beutler e, grabowski ga. gaucher disease. in: metabolic and molecular bases of inherited disease, scriver cr, beaudet al, sly ws, valle d (eds), mcgraw-hill, new york 2001: 3635. 2. cox tm, schofield jp.   gaucher’s diseas...

background: metabolic bone diseases (mbd), including rickets and osteopenia, are important neonatal complications among preterm infants. this study aimed to determine the prevalence and risk factors of mbd in neonates with very low birth weight (vlbw). methods: this prospective study was conducted on vlbw infants from january 2012 to july 2013. inclusion criteria were birth weight of ≤1500 g an...

the factors such as disease can disrupt homeostasis, resulting in perturbations of endogenous biochemicals that are involved in key metabolic profiles. metabonomics is useful technique to quantitative description of endogenous metabolites present in a biological sample such as urine, plasma and tissue. high resolution 1 h nuclear magnetic resonance (nmr)-based metabonomics is a technique used t...

diabetes is a chronic disease of lifelong duration, and its management requires a fundamental change in the patient’s lifestyle. the aims of this study were to determine behaviors of diabetic patients in relation to management of their disease, assess metabolic control and health-related quality of life of them. the target population was type 2 diabetic patients and a cross-sectional approach w...